M S SCHWARTZ - JoVE Visualize

Showing results (101-110 of 113) with videos related to

Pageof 12

Sort By:

Journal of Neurosurgery|April 8, 1999

Use of the radial forearm microvascular free-flap graft for cranial base reconstructionM S Schwartz, J I Cohen, T Meltzer, et al.

Journal of Internal Medicine|January 23, 1998

Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatinL Gullestad, K P Nordal, K Forfang, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1989

The physiological disposition of lovastatinD E Duggan, I W Chen, W F Bayne, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994

Metabolic disposition of simvastatin in patients with T-tube drainageH Cheng, M S Schwartz, S Vickers, et al.

Surgical Neurology|December 24, 1997

The use of clinical practice guidelines (CPGs) to evaluate practice and control costs in ventriculoperitoneal shunt managementJ K Park, D M Frim, M S Schwartz, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studiesP F Smith, R S Eydelloth, S J Grossman, et al.

Journal of Medicinal Chemistry|June 1, 1986

Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonistsR M DeMarinis, G Gallagher, R F Hall, et al.

Pharmaceutical Research|November 1, 1993

Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humansH Cheng, S C Sutton, J D Pipkin, et al.

The Journal of Clinical Endocrinology and Metabolism|December 22, 1999

Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neuronsH Jung, P Carmel, M S Schwartz, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouseK P Vyas, P H Kari, S M Pitzenberger, et al.

Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:

Pageof 12

Journal of Neurosurgery|April 8, 1999

Use of the radial forearm microvascular free-flap graft for cranial base reconstructionM S Schwartz, J I Cohen, T Meltzer, et al.

Journal of Internal Medicine|January 23, 1998

Post-transplant hyperlipidaemia: low-dose lovastatin lowers atherogenic lipids without plasma accumulation of lovastatinL Gullestad, K P Nordal, K Forfang, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1989

The physiological disposition of lovastatinD E Duggan, I W Chen, W F Bayne, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1994

Metabolic disposition of simvastatin in patients with T-tube drainageH Cheng, M S Schwartz, S Vickers, et al.

Surgical Neurology|December 24, 1997

The use of clinical practice guidelines (CPGs) to evaluate practice and control costs in ventriculoperitoneal shunt managementJ K Park, D M Frim, M S Schwartz, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 1, 1991

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studiesP F Smith, R S Eydelloth, S J Grossman, et al.

Journal of Medicinal Chemistry|June 1, 1986

Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonistsR M DeMarinis, G Gallagher, R F Hall, et al.

Pharmaceutical Research|November 1, 1993

Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humansH Cheng, S C Sutton, J D Pipkin, et al.

The Journal of Clinical Endocrinology and Metabolism|December 22, 1999

Some hypothalamic hamartomas contain transforming growth factor alpha, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neuronsH Jung, P Carmel, M S Schwartz, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990

Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouseK P Vyas, P H Kari, S M Pitzenberger, et al.

Pageof 12